Dual-low spectral CT pulmonary angiography: a comparative study of image quality, radiation dose, and iodine intake with evaluation of pulmonary embolism detection - Report - MDSpire
Advertisement
Dual-low spectral CT pulmonary angiography: a comparative study of image quality, radiation dose, and iodine intake with evaluation of pulmonary embolism detection
Clinical Report: Comparative Analysis of Dual-Low Spectral CT Pulmonary Angiography
Overview
This study evaluates a dual-low CT pulmonary angiography (CTPA) protocol that integrates spectral CT and low iodine dose, demonstrating significant reductions in radiation exposure and iodine intake while maintaining image quality.
Background
CT pulmonary angiography (CTPA) is the first-line imaging modality for pulmonary embolism (PE) due to its rapid and accurate characteristics. However, concerns regarding radiation exposure and contrast-induced acute kidney injury have prompted the development of dual-low protocols. These protocols aim to minimize both radiation and iodine contrast doses while preserving diagnostic image quality.
Data Highlights
Parameter
Experimental Group
Control Group
Effective Radiation Dose (ED)
2.51 ± 0.59 mSv
4.27 ± 0.94 mSv
Iodine Intake
3.5 g
10.5 g
Subjective Image Quality Score
2.69 ± 0.44
2.33 ± 0.44
PE Detection Rate
53.7% (43/80)
38.7% (31/80)
Key Findings
Effective radiation dose reduced by 41.2%.
Iodine intake reduced by 66.7% compared to conventional CTPA.
Subjective image quality scores were higher in the experimental group (p < 0.001).
Contrast-to-noise ratio (CNR) in the experimental group exceeded the diagnostic threshold.
Iodine density maps visualized perfusion defects.
Clinical Implications
The dual-low spectral CTPA protocol offers a promising alternative for imaging in suspected pulmonary embolism, significantly reducing both radiation exposure and iodine contrast usage. This approach may enhance patient safety while maintaining diagnostic efficacy.
Conclusion
The findings support the dual-low spectral CTPA protocol as a safe and effective method for diagnosing pulmonary embolism, with notable reductions in radiation and iodine contrast doses.